<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-7-369</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20163.101</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Angioedema associated with Helicobacter pylori and type 2 diabetes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sokolova</surname>
<given-names>Raditsa</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dermendzhiev</surname>
<given-names>Svetlan</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yankova</surname>
<given-names>Rumyna</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Dermatology and Venereology, Medical University Plovdiv, University Hospital of Plovdiv, Plovdiv, Bulgaria</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Allergologyand Occupational Medicine, Medical University Plovdiv, University Hospital of Plovdiv, Plovdiv, Bulgaria</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Raditsa Sokolova, E-mail: <email xlink:href="radica.sokolova@gmail.com">radica.sokolova@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>Suppl 1</issue>
<fpage>369</fpage>
<lpage>371</lpage>
<history>
<date date-type="received"><day>27</day><month>06</month><year>2016</year></date>
<date date-type="accepted"><day>23</day><month>07</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 4</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Angioedema without wheals with duration of symptoms over six weeks is relatively rare. This applies especially for the chronic forms of angioedema associated with metabolic, infectious, malignant, and systemic connective tissue disease. Described in the literature cases are rare, especially when the etiology of isolated angioedema associated with Helicobacter pylori and type 2 diabetes. We report a case of a 66-year-old male patient with recurrent isolated angioedema without wheals, affecting the upper lip, with a disease duration of one year and no symptoms of respiratory and gastrointestinal tract. Laboratory, immunological and serological studies we found only elevated blood sugar and elevated Anti Helicobacter pylori IgG antibody. In patients with type 2 diabetes mellitus etiology of angioedema may be associated with Helicobacter pylori and poor metabolic control. To be an effective treatment, the etiology of such phenomena should be precisely clarified with the respective set of immunological and serological tests.</p>
</abstract>
<kwd-group>
<kwd>Angioedema</kwd>
<kwd>Helicobacter pylori</kwd>
<kwd>Type 2 diabetes</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Chronic urticaria/angioedema is defined as wheals, angioedema or both with daily or almost daily symptoms lasting for more than 6 weeks [<xref ref-type="bibr" rid="ref1">1</xref>]. Angioedema is characterized by localized, self-limiting, nonpitting swelling of the skin and/or of the mucous membranes of the upper respiratory and gastrointestinal tracts [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Most guidelines include isolated angioedema as a subtype of chronic spontaneous urticaria [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref6">6</xref>]. About 10&#x0025; of patients with chronic spontaneous urticaria do not show wheals and exclusively develop angioedema [<xref ref-type="bibr" rid="ref7">7</xref>]. Angioedema without wheals with duration of symptoms over six weeks is relatively rare. The most common forms of chronic and isolated angioedema are induced by medications such as angiotensin-converting enzyme inhibitors (ACE inhibitors), nonsteroidal anti-inflammatory agents and antibiotics. Hereditary angioedema with different types is also part of the chronic isolated forms of angioedema, and their diagnosis is important for proper treatment [<xref ref-type="bibr" rid="ref1">1</xref>]. On the other hand, isolated angioedema associated with metabolic abnormalities, and laboratory evidence of infection with Helicobacter pylori is more rarely [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>]. Various etiologic factors, the broad range of immunological and non-immunological changes reflecting the pathogenetic mechanisms and defining forms of urticaria and angioedema often create diagnostic and differential diagnostic difficulties for dermatologists and allergists. This is especially true for the chronic forms, the more that they sometimes establish an association with a number of accompanying metabolic, infectious, malignant, systemic connective tissue diseases and others.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>We present a case of 66-year-old male patient with recurrent isolated angioedema without wheals, affecting the upper lip (<xref ref-type="fig" rid="F1">Fig. 1</xref>), with disease duration of one year and without symptoms of respiratory and gastrointestinal tract. The patient reported only numbness of the upper lip a few hours before the start of angioedema. With a history of acute episode of angioedema with wheals 7 years ago, drug induced by a single dose of ACE-inhibitor (enalapril maleate). Without family history of atopy and other allergic diseases. He suffers from type 2 diabetes and hypertension. His daily treatment included diet for type 2 diabetes and chlophasolin 0,15 mg/day for hypertension. Except angioedema localizated to upper lip (<xref ref-type="fig" rid="F1">Fig. 1</xref>), findings from the physical and dermatology examination and are unremarkable.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Angioedema without wheals, affecting the upper lip.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-7-369-g001.tif"/>
</fig>
<p>The hematology and blood differential tests were in reference ranges. Total bilirubin, total protein, albumin, urea, ALT, AST and electrolytes in blood were normal expect blood glucosae levels was elevated 8,18 mmol/l (reference ranges 3,3-6, 0 mmol/l). Anti-thyreoglobulin (anti-TG) and anti-peroxidase (anti-TPO) antibodies, TSH and FT4 were normal. C1 inhibitor levels, C4 serum complement levels, IgA, IgG, and total IgE were in reference ranges. Anti-Toxoplasma gondii IgM and IgG titer were negative. Anti Helicobacter pylori IgG antibody titer was positive 55 IU,ml (reference ranges &#x003C; 20 IU,ml), but the Helicobacter pylori stool antigen was negative. Stool tests for enteroparasites (Giardia lamblia, Amoebiasis and Blastocystis hominis) were negative. Abdominal ultrasound was normal.</p>
<p>We started treatment with levocetirizine dihydrochloride 10 mg/daily for 6 months and Metformin 1000 mg/daily. Attacks of angioedema disappeared. After discontinuing treatment with an levocetirizine dihydrochloride patient is in complete remission, asymptomatic and without recurrence of angioedema (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Patient without angioedema.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-7-369-g002.tif"/>
</fig>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Type 2 diabetes is one of the diseases often associated with the etiology of chronic urticaria. As unlockable clinical manifestations of urticaria factors indicating unsatisfactory metabolic control and received antidiabetic drugs, many of which rash and itching are cited as more frequent or rare side effects. Hypertension is a common comorbidity in patients with diabetes. The American Diabetes Association guidelines recommend the use of either ACE inhibitors or angiotensin receptor blocker (ARB) as initial therapy to achieve the blood pressure target in patients with type 2 diabetes mellitus [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>]. One of the most common causes of drug-related angioedema is from ACE inhibitor [<xref ref-type="bibr" rid="ref1">1</xref>]. Our patient had a medical history of drug-related angioedema from ACE inhibitor. Angioedema is also seen with ARB therapy but much less frequently than with ACE inhibitors [<xref ref-type="bibr" rid="ref11">11</xref>]. On the other hand, antidiabetic drugs-Dipeptidyl peptidase-IV inhibitor are also associated with angioedema and increase angioedema risk in patients treated with ACE inhibitors [<xref ref-type="bibr" rid="ref12">12</xref>]. In our patient, laboratory testing showed elevated blood glucose levels. Rogala et al. associated isolated angioedema with elevated blood glucose levels and impaired glucose tolerance. The reasons for this remain unclear. It may be that impaired glucose tolerance and high glucose levels contribute to the development of recurrent angioedema [<xref ref-type="bibr" rid="ref7">7</xref>]. In our patient, serology testing showed elevated Anti Helicobacter pylori IgG antibody titer. Described in the literature cases of isolated angioedema induced from Helicobacter pylori are rare and the treatment designed to eradicate the infection shows no significant results [<xref ref-type="bibr" rid="ref8">8</xref>].</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>CONCLUSION</title>
<p>Isolated angioedema without wheals induced by the combination of various factors presented our case is a rare phenomenon. In patients with type 2 diabetes mellitus etiology of angioedema may be associated with Helicobacter pylori and poor metabolic control. To be an effective treatment, the etiology of such phenomena should be precisely clarified with the respective set of immunological and serological tests.</p>
<sec id="sec2-1">
<title>Consent</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Leech</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Till</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Nasser</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>AT</given-names>
</name>
<collab>British Society for Allergy and Clinical Immunology</collab>
</person-group>
<article-title>BSACI guideline for the management of chronic urticaria and angioedema</article-title>
<source>Clin Exp Allergy</source>
<year>2015</year>
<volume>45</volume>
<fpage>547</fpage>
<lpage>65</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mansi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanichelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coerezza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Suffritti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Vacchini</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients</article-title>
<source>J Intern Med</source>
<year>2015</year>
<volume>277</volume>
<fpage>585</fpage>
<lpage>93</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Angioedema</article-title>
<source>World Allergy Organ J</source>
<year>2008</year>
<volume>1</volume>
<fpage>103</fpage>
<lpage>13</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bartra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gim&#233;nez-Arnau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jauregui</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Labrador-Horrillo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ortiz de Frutos</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Management of urticaria: Not too complicated, not too simple</article-title>
<source>Clin Exp Allergy</source>
<year>2015</year>
<volume>45</volume>
<fpage>731</fpage>
<lpage>43</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuberbier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aberer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Asero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bindslev-Jensen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brzoza</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Canonica</surname>
<given-names>GW</given-names>
</name>
<etal/>
</person-group>
<article-title>The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: The 2013 revision and update</article-title>
<source>Allergy</source>
<year>2014</year>
<volume>69</volume>
<fpage>868</fpage>
<lpage>87</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hide</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hiragun</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries</article-title>
<source>Allergol Int</source>
<year>2012</year>
<volume>61</volume>
<fpage>517</fpage>
<lpage>27</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogala</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bozek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gl&#252;ck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rymarczyk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jarzab</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maurer</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Coexistence of angioedema alone with impaired glucose tolerance</article-title>
<source>Int Arch Allergy Immunol</source>
<year>2014</year>
<volume>165</volume>
<fpage>265</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leiding</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Beakes</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dreskin</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Grumach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hide</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reshef</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Triggiani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaliner</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions</article-title>
<source>World Allergy Organ J</source>
<year>2014</year>
<volume>22</volume>
<issue>7</issue>
<fpage>2</fpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title>Standards of medical care in diabetes</article-title>
<source>Diabetes Care</source>
<year>2005</year>
<volume>28</volume>
<fpage>4</fpage>
<lpage>36</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title>Treatment of Hypertension in Adults With Diabetes</article-title>
<source>Diabetes Care</source>
<year>2002</year>
<volume>25</volume>
<fpage>71</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sica</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>HR</given-names>
</name>
</person-group>
<article-title>Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy</article-title>
<source>Congest Heart Fail</source>
<year>2002</year>
<volume>8</volume>
<fpage>334</fpage>
<lpage>41</lpage>
<comment>345</comment>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Byiers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maldonado</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema</article-title>
<source>Hypertension</source>
<year>2009</year>
<volume>54</volume>
<fpage>516</fpage>
<lpage>23</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>